Carlos A.M. Campos

Showing 1-10 of 10 articles

Assessment of long-term mortality in patients with complex coronary artery disease undergoing percutaneous intervention: comparison of multiple anatomical and clinical prognostic risk scores

Janella B, Campos C, Caixeta A, Almeida B, Sandoli de Brito Jr F, Abizaid A, Perin M

November 20, 2017 | 10.4244/EIJ-D-16-00659

Interventions for valvular disease

The interaction of de novo and pre-existing aortic regurgitation after TAVI: insights from a new quantitative aortographic technique

Tateishi H, Abdelghani M, Cavalcante R, Miyazaki Y, Campos C, Collet C, Slots T, Leite R, Mangione J, Abizaid A, Soliman O, Spitzer E, Onuma Y, Serruys P, Lemos P, de Brito Jr F

May 15, 2017 | 10.4244/EIJ-D-16-00647

Coronary interventions

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease

Escaned J, Banning A, Farooq V, Echavarría-Pinto M, Onuma Y, Ryan N, Cavalcante R, Campos C, Stanetic B, Ishibashi Y, Suwannasom P, Kappetein A, Taggart D, Morel M, Van Es G-A, Serruys P

June 10, 2016 | 10.4244/EIJV12I2A36

Interventions for valvular disease

Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry

Tateishi H, Campos C, Abdelghani M, Leite R, Mangione J, Bary L, Soliman O, Spitzer E, Perin M, Onuma Y, Serruys P, Lemos P, Brito F

March 18, 2016 | 10.4244/EIJV11I12A271

Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index

Généreux P, Campos C, Yadav M, Palmerini T, Caixeta A, Xu K, Francese D, Dangas G, Mehran R, Leon M, Serruys P, Stone G

October 20, 2015 | 10.4244/EIJY14M10_05

Coronary interventions

The EXCEL and NOBLE trials: similarities, contrasts and future perspectives for left main revascularisation

Campos C, Christiansen E, Stone G, Serruys P

May 19, 2015 | 10.4244/EIJV11SVA26

Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial

Zhang Y-J, Bourantas C, Muramatsu T, Iqbal J, Farooq V, Diletti R, Campos C, Onuma Y, Garcia-Garcia H, Serruys P

October 20, 2014 | 10.4244/EIJV10I6A118

First-in-man randomised comparison of a novel sirolimus-eluting stent with abluminal biodegradable polymer and thin-strut cobalt-chromium alloy: INSPIRON-I trial

Ribeiro E, Campos C, Ribeiro H, Lopes A, Esper R, Meireles G, Perin M, Abizaid A, Lemos P

April 22, 2014 | 10.4244/EIJV9I12A234

Transcatheter aortic valve update 2013

Bourantas C, Van Mieghem N, Soliman O, Campos C, Iqbal J, Serruys P

September 15, 2013 | 10.4244/EIJV9SSA16

Prognostic heterogeneity among patients with chronic stable coronary disease: determinants of long-term mortality after treatment with percutaneous intervention

Lemos P, Campos C, FalcÃ£o J, Ribeiro E, Perin M, Kajita L, Filho E, da Gama M, Horta P, Marchiori G, Spadaro A, Martinez E

June 30, 2009 | 10.4244/EIJV5I2A37

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

News

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

March 4, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

March 2, 2021

Guidance Papers

Guidelines, consensus & position papers